Steven Kornblau - Dokumente zum Namen - alle Infos bei Yasni.de

(1 - 6 von 7

)

Is it time to consider targeted therapy in combination for newly diag…

www.slideshare.net

Is it time to consider targeted therapy in combination for newly diagnosed AML? Prof. Steven Kornblau

A Phase II Study of Omacetaxine Mepesuccinate for Patients with...

papers.ssrn.com

Koichi Takahashi ... Steven Kornblau. University of Texas at ...

Buparlisib, a PI3K inhibitor, demonstrates acceptable ...Wiley Online Library

onlinelibrary.wiley.com

von BK Ragon · · Zitiert von: 40 — ... Steven Kornblau,. Steven Kornblau. Department of Leukemia, The ... Steven Kornblau, William Wierda, Jan Burger, Courtney DiNardo, Michael ...

Disruption of Wnt/β-Catenin Exerts Antileukemia Activity and ...aacrjournals.org

aacrjournals.org

von X Jiang · · Zitiert von: 69 — Steven Kornblau;. Steven Kornblau. 1Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center ...

TRP

trp.cancer.gov

Steven Kornblau, M.D.. Core Co-Directors: Michael Wang, M.D.. R. Eric Davis, M.D.. Pei Lin, M.D.. Basic, translational, and clinical scientists ...

OASIS

www.abstractsonline.com

... A. Burger, Michael Andreeff, Wenbin Liu, Steven M. Kornblau, Keith Baggerly, ... University of Duisburg-Essen, Essen, Germany;Institut Bergonié, Bordeaux, ...

Verwandte Suchanfragen zu Steven Kornblau

Michael Keating

Personen
Vorname "Steven" (16084)
Name "Kornblau" (8)

sortiert nach Relevanz / Datum

Erweiterte Suche

Person-Suchen: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Dokumente zum Namen Steven Kornblau

Is it time to consider targeted therapy in combination for newly diag…

A Phase II Study of Omacetaxine Mepesuccinate for Patients with...

Buparlisib, a PI3K inhibitor, demonstrates acceptable ...Wiley Online Library

Disruption of Wnt/β-Catenin Exerts Antileukemia Activity and ...aacrjournals.org

TRP

OASIS